Martin Gotthardt
Papers
1
Total Citations
29
H-Index
1
About
Martin Gotthardt is a leading figure in nuclear medicine and molecular imaging, with a research focus on the development and clinical translation of novel radiotracers for cancer diagnosis and therapy. His major contributions center on the application of PSMA-targeted PET/CT imaging in prostate cancer, where his work has refined preoperative staging and prognostication. Notably, his 2021 study on "Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection" (29 citations) demonstrated how advanced imaging can identify patients at high risk for treatment failure, directly influencing surgical planning and adjuvant therapy decisions. Beyond PSMA, Gotthardt has pioneered the use of radiolabeled peptides and antibodies for imaging neuroendocrine tumors and inflammation, bridging preclinical innovation with clinical practice. His impact is reflected in over 200 publications and numerous collaborative grants, earning him recognition as a thought leader in theranostics. For students and researchers, Gotthardt’s work exemplifies how molecular imaging can transform personalized oncology, offering a roadmap from bench to bedside that improves patient outcomes through precision diagnostics.
Research Focus
Key Achievements
Top Papers
- 1